"A Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched and HLA-Matched Bone Marrow for Patients with Sickle Cell Disease and Other Hemoglobinopathies "

drug protocol number
CT20/008/R
drug sponsor
KAIMRC
drug study
HYDROXYUREA (HYDROXYCARBAMIDE)
drug trial site
King Abdulaziz Medical City NG (Riyadh)
drug status
Ongoing
drug phase